Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Phillip Buckhaults"'
Autor:
Monish Ram Makena, Myungjun Ko, Allatah X. Mekile, Nanami Senoo, Donna K. Dang, John Warrington, Phillip Buckhaults, C. Conover Talbot, Jr., Steven M. Claypool, Rajini Rao
Publikováno v:
Redox Biology, Vol 50, Iss , Pp 102240- (2022)
A complex interplay between the extracellular space, cytoplasm and individual organelles modulates Ca2+ signaling to impact all aspects of cell fate and function. In recent years, the molecular machinery linking endoplasmic reticulum stores to plasma
Externí odkaz:
https://doaj.org/article/0b300ccbdec4497a989595ebae280235
Broccoli sprout (BSp) diet nutritional profile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278eae5bd9cd6aacbf01aa7662785037
https://doi.org/10.1158/1940-6207.22534495.v1
https://doi.org/10.1158/1940-6207.22534495.v1
Breast cancer is the most common cancer and the second leading cause of cancer-related death among women. An important risk factor for breast cancer is individual genetic background, which is initially generated early in human life, for example, duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b0a24ee686bd71242388f53e93ba99
https://doi.org/10.1158/1940-6207.c.6547519.v1
https://doi.org/10.1158/1940-6207.c.6547519.v1
Autor:
Trung Vu, Bixiang Zhang, Pran K. Datta, Kasturi Mitra, Sejong Bae, Carolyn E. Banister, Lin Jin, Isam-Eldin Eltoum, Arunima Datta, Upender Manne, Guandou Yuan, Robert S. Welner, Temesgen Samuel, Phillip Buckhaults
Publikováno v:
Gastroenterology
Background & Aims Inactivation of the Apc gene is a critical early event in the development of sporadic colorectal cancer (CRC). Expression of serine-threonine kinase receptor-associated protein (STRAP) is elevated in CRCs and is associated with poor
Autor:
Jennifer Emmel, Kim E. Creek, Phillip Buckhaults, Carolyn E. Banister, Fadi F. Abboodi, Lucia Pirisi, Ariana Renrick, Nella C. Delva
Publikováno v:
Genome Instability & Disease. 2:71-91
High-risk human papillomaviruses (HPV) cause 5% of all human cancers and are primary etiologic agents of cervical, anal, and oropharyngeal cancer. HPV infection is necessary, but not sufficient per se to produce cancer: additional changes must occur
Autor:
Kim E. Creek, Phillip Buckhaults, Maria Hosseinipour, Fadi F. Abboodi, Lucia Pirisi, Carolyn E. Banister, Changlong Liu, Diego Altomare
Publikováno v:
Virology. 554:9-16
HPV-inactive head and neck and cervical cancers contain HPV DNA but do not express HPV E6/E7. HPV-positive primary head and neck tumors usually express E6/E7, however they may produce HPV-inactive metastases. These observations led to our hypothesis
Autor:
Pelin Gülizar Ersan, Fatma Gundogdu, Aysegul Uner, Vitali Sikirzhytski, Unal Metin Tokat, Aysegul Kaymak, Phillip Buckhaults, Hayriye Tatlı Doğan, Gamze Aykut, Carolyn E. Banister, Kemal Kosemehmetoglu, Omer Dizdar, Suhail A. Ansari, Umar Raza, Mehmet Dogan, Ozge Saatci, Ozgur Sahin, Aynur Isik, Ozge Akbulut, Sercan Aksoy, Aytekin Akyol, Yasser Riazalhosseini, Pouria Jandaghi
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Nature Communications
Nature Communications
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresist
Autor:
Monish Ram, Makena, Myungjun, Ko, Allatah X, Mekile, Nanami, Senoo, Donna K, Dang, John, Warrington, Phillip, Buckhaults, C Conover, Talbot, Steven M, Claypool, Rajini, Rao
Publikováno v:
Redox Biology
A complex interplay between the extracellular space, cytoplasm and individual organelles modulates Ca2+ signaling to impact all aspects of cell fate and function. In recent years, the molecular machinery linking endoplasmic reticulum stores to plasma
Publikováno v:
Cancer Res
TP53 mutations are common in most human cancers, but few therapeutic options for TP53-mutant tumors exist. To identify potential therapeutic options for cancer patients with TP53 mutations, we profiled 127 FDA-approved chemotherapy drugs against huma
Autor:
Donna K. Dang, Phillip Buckhaults, Rajini Rao, Myungjun Ko, C. Conover Talbot, Allatah X. Mekile, Monish Ram Makena, John Warrington
SUMMARYAlthough the mainstay of treatment for hormone responsive breast tumors is targeted endocrine therapy, many patients develop de novo or acquired resistance and are treated with chemotherapeutic drugs. The vast majority (80%) of estrogen recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bcacc088726f6c3a4dd8250eb167e41